Medicaid policies that require patients to undergo counseling in order to receive medications to quit smoking, in fact end up affecting the use of these medications, according to a new study.
Medicaid policies that require patients to undergo counseling in order to receive medications to quit smoking, in fact end up affecting the use of these medications, according to a new study. Put simply, if the Medicaid beneficiaries possess incomplete information about the tobacco-cessation programs, the counseling sessions do no good to smokers who want to quit and become a barrier to their efforts.
The study, published in the CDC’s Preventing Chronic Disease journal, talks about the barriers created by Medicaid programs for smokers who want to quit. Leighton Ku, PhD, MPH, professor of health policy and management at Milken Institute School of Public Health, Washington, DC, and fellow colleagues compiled the report to highlight the irony of such Medicaid policies.
“Many organizations encourage coverage of all FDA-approved cessation medications and counseling and elimination of barriers that might limit access,” the authors wrote. “However, these benefits may go unused if patients and physicians are unaware that they are available or are not sufficiently engaged to attempt quitting. Fewer than half of smokers in Medicaid-managed care plans reported that their physicians offered assistance, such as medications or counseling, to quit.”
Smoking—A Double Whammy
In US, smoking is the leading cause of preventable illness and disease. Furthermore, almost one-third of adults covered by Medicaid, the nation’s largest health insurance program, smokes.
By quitting, smokers can drastically reduce the risk of deadly smoking-related diseases such as lung cancer. And such policies that help smokers quit are an investment that pays off for the Medicaid program, because tobacco-related diseases cost the Medicaid program a huge amount every year. If smokers quit, a major chunk of these health expenses can be prevented.
“Policies and programs that empower low-income Medicaid smokers to quit could improve their health and help reduce healthcare costs,” Ku said in a statement.
Counseling: A Building Block or a Hurdle?
When the authors examined state-level differences in the use of anti-smoking medications by Medicaid patients between 2010 and 2014, they found that the counseling requirement in fact became a barrier to quitting smoking.
The counseling sessions are designed to help smokers quit. However, the benefits may go unused if patients and physicians are unaware of their availability in the first place. More than 50% of smokers in Medicaid-managed care plans said that their physicians were not as invested in offering assistance in terms of medications or counseling, to quit.
It is imperative for states to increase efforts to develop more comprehensive coverage and reduce barriers to coverage because:
By empowering patients and providers to increase awareness of cessation benefits and undertake the difficult challenge of quitting, states can drastically reduce healthcare costs while positively impacting health. This would also prevent relapses.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More